Shigeki Nakamura
Second Tokushima Institute of New Drug Research
Otsuka Pharmaceutical Co. Ltd.
463-10
Kagasuno
Japan
Name/email consistency: high
- Antidiuretic effects of a novel nonpeptide vasopressin V(2)-receptor agonist, OPC-51803, administered orally to dogs. Nakamura, S., Hirano, T., Onogawa, T., Itoh, S., Hashimoto, A., Yamamura, Y., Kondo, K., Mori, T., Kambe, T. J. Pharmacol. Sci. (2004)
- Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes. Nakamura, S., Yamamura, Y., Itoh, S., Hirano, T., Tsujimae, K., Aoyama, M., Kondo, K., Ogawa, H., Shinohara, T., Kan, K., Tanada, Y., Teramoto, S., Sumida, T., Nakayama, S., Sekiguchi, K., Kambe, T., Tsujimoto, G., Mori, T., Tominaga, M. Br. J. Pharmacol. (2000)
- Antidiuretic effects of a nonpeptide vasopressin V(2)-receptor agonist, OPC-51803, administered orally to rats. Nakamura, S., Hirano, T., Tsujimae, K., Aoyama, M., Kondo, K., Yamamura, Y., Mori, T., Tominaga, M. J. Pharmacol. Exp. Ther. (2000)